• Subscribe Now
  • Cannabis News
    • Business News
    • Adult Use
    • Medical
    • Policy & Legislation
    • Hemp & CBD
    • International
  • Insights
    • Featured Announcements
    • Q&A Interviews
    • Podcasts
    • Vocabulary
  • Resources
    • Service Providers
    • Cannabis Brands
    • Dispensaries
    • Upcoming Events
  • Connect
    • Become a Subscriber
    • About Ganjapreneur
    • Contact Us
    • Partner With Us
    • Submit an Announcement
  • Subscriber Login
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube
Skip to content
  • Subscriber Login
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube
Ganjapreneur

Ganjapreneur

Cannabis Business Information Since 2014

  • Cannabis News
    • Business News
    • Adult Use
    • Medical
    • Policy & Legislation
    • Hemp & CBD
    • International
  • Insights
    • Featured Announcements
    • Q&A Interviews
    • Podcasts
    • Vocabulary
  • Resources
    • Service Providers
    • Cannabis Brands
    • Dispensaries
    • Upcoming Events
  • Connect
    • Become a Subscriber
    • About Ganjapreneur
    • Contact Us
    • Partner With Us
    • Submit an Announcement
  • Subscribe Now
  • News Categories
  • Latest News
  • Business
  • Policy & Legislation
  • Medical Cannabis
  • Adult Use
  • Hemp & CBD
Home //
FDA

The US Food and Drug Administration (FDA) is currently working to understand how cannabis and isolated CBD products can be useful to American citizens. There are robust statistics and stories emerging as the FDA conducts cannabis research. Read more about these details in the following stories, and sign up for our newsletter to be the first to find out when news hits the wire.


|

Big Pharma Positioning for Federal Approval of Cannabis Drugs

Cannabis PolicyHemp Industry NewsMedical CannabisNews BriefsOpinions & EditorialsRecreational
by Graham AbbottApril 4, 2017July 3, 2025
A young hemp crop planted legally in the U.S. under the 2014 Congressional Farm Bill.

Hemp CBD Companies Should Worry About FDA, Not DEA, Intervention

Cannabis Industry NewsHemp Industry NewsNews Briefs
by Graham AbbottFebruary 8, 2017July 3, 2025
Donald Trump was elected to be the 45th president in November

Trump Considering Cannabis Advocate for FDA Commissioner

Cannabis PolicyMarijuana News BriefsMedical CannabisNews Briefs
by Graham AbbottJanuary 24, 2017July 3, 2025

Posts pagination

Newer posts 1 … 6 7 8

Featured Subscriber:

Ganjapreneur is made possible by our business subscribers. Subscribe today

Cannabis News

  • Latest News
  • Business
  • Policy & Legislation
  • Medical Cannabis
  • Adult Use
  • Hemp & CBD

Insights

  • Podcasts
  • Q&A Interviews
  • Featured Announcements
  • Science & Research
  • Vocabulary

Resources

  • Services & Equipment
  • Cannabis Brands
  • Dispensaries
  • Upcoming Events

US Markets

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Iowa
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • Washington DC
  • West Virginia
  • Wisconsin
  • Wyoming

International

  • View All
  • Amsterdam
  • Asia
  • Argentina
  • Australia
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • Guam
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Morocco
  • New Zealand
  • Puerto Rico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Thailand
  • Ukraine
  • Uruguay

Ganjapreneur

Grassroots cannabis business intelligence.

  • About us
  • Contact us
  • Become a subscriber
  • Partner with us
© 2025 Ganjapreneur Site by Bluedream
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube

All rights reserved. // Terms of Use // Advertising Policy // Privacy Policy


DISCLAIMER: Ganjapreneur.com is intended as an educational resource for law-abiding professionals and those who are curious about entrepreneurial and/or investment opportunities in emerging markets. We do not offer investment advice, and we encourage all visitors and readers to do their own due dilligence before investing in any of the companies or markets that we write about. Be advised that possessing, using, distributing and selling cannabis are all federal crimes in the United States of America and the articles, pages, links, and other types of information on this site are not intended to assist you in violating federal law. Ganjapreneur.com and all associated entities and individuals are not responsible for third party content and/or links published on this website.